1. Home
  2. FOXX vs XLO Comparison

FOXX vs XLO Comparison

Compare FOXX & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOXX
  • XLO
  • Stock Information
  • Founded
  • FOXX 2017
  • XLO 2016
  • Country
  • FOXX United States
  • XLO United States
  • Employees
  • FOXX N/A
  • XLO N/A
  • Industry
  • FOXX
  • XLO Biotechnology: Pharmaceutical Preparations
  • Sector
  • FOXX
  • XLO Health Care
  • Exchange
  • FOXX Nasdaq
  • XLO Nasdaq
  • Market Cap
  • FOXX 34.2M
  • XLO 37.9M
  • IPO Year
  • FOXX N/A
  • XLO 2021
  • Fundamental
  • Price
  • FOXX $4.53
  • XLO $0.93
  • Analyst Decision
  • FOXX
  • XLO Buy
  • Analyst Count
  • FOXX 0
  • XLO 1
  • Target Price
  • FOXX N/A
  • XLO $4.00
  • AVG Volume (30 Days)
  • FOXX 1.8M
  • XLO 10.6M
  • Earning Date
  • FOXX 02-14-2025
  • XLO 03-31-2025
  • Dividend Yield
  • FOXX N/A
  • XLO N/A
  • EPS Growth
  • FOXX N/A
  • XLO N/A
  • EPS
  • FOXX N/A
  • XLO N/A
  • Revenue
  • FOXX $42,988,015.00
  • XLO $4,620,000.00
  • Revenue This Year
  • FOXX N/A
  • XLO N/A
  • Revenue Next Year
  • FOXX N/A
  • XLO $558.79
  • P/E Ratio
  • FOXX N/A
  • XLO N/A
  • Revenue Growth
  • FOXX 98.81
  • XLO N/A
  • 52 Week Low
  • FOXX $2.45
  • XLO $0.55
  • 52 Week High
  • FOXX $14.99
  • XLO $1.93
  • Technical
  • Relative Strength Index (RSI)
  • FOXX N/A
  • XLO 48.99
  • Support Level
  • FOXX N/A
  • XLO $0.97
  • Resistance Level
  • FOXX N/A
  • XLO $1.22
  • Average True Range (ATR)
  • FOXX 0.00
  • XLO 0.14
  • MACD
  • FOXX 0.00
  • XLO 0.03
  • Stochastic Oscillator
  • FOXX 0.00
  • XLO 28.04

About FOXX Foxx Development Holdings Inc. Common Stock

Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

Share on Social Networks: